These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 38521112)
1. Identify CTBP1-DT as an immunological biomarker that promotes lipid synthesis and apoptosis resistance in KIRC. Li H; Fei M; Zhang Y; Xu Q; Feng R; Cao J; Qu Y; Xiao H Gene; 2024 Jul; 914():148403. PubMed ID: 38521112 [TBL] [Abstract][Full Text] [Related]
2. SLC11A1 promotes kidney renal clear cell carcinoma (KIRC) progression by remodeling the tumor microenvironment. Wu D; Zhou Y; Shi X; Yi X; Sheng Z; Fan L; Ge J; Cheng W; Zhou W; He H; Fu D Toxicol Appl Pharmacol; 2024 Jun; 487():116975. PubMed ID: 38762191 [TBL] [Abstract][Full Text] [Related]
3. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription. Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker. Zhang D; Liang P; Xia B; Wu J; Hu X BMC Cancer; 2024 Aug; 24(1):987. PubMed ID: 39123194 [TBL] [Abstract][Full Text] [Related]
5. Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing. Zhang X; Zhou J; Wang Y; Wang X; Zhu B; Xing Q Biochem Genet; 2024 Jun; 62(3):1502-1520. PubMed ID: 37642814 [TBL] [Abstract][Full Text] [Related]
6. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1. Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W J Cell Physiol; 2021 Jan; 236(1):427-439. PubMed ID: 32583425 [TBL] [Abstract][Full Text] [Related]
7. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling. Ye Y; Zhang F; Chen Q; Huang Z; Li M Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578 [TBL] [Abstract][Full Text] [Related]
8. Troponin T1 in tumorigenesis and immune modulation: Insights into multiple cancers and kidney renal clear cell carcinoma. Zhang Q; Hao L; Wang F; Yu Q; Wu S; Han C J Cell Mol Med; 2024 Jun; 28(11):e18410. PubMed ID: 38853457 [TBL] [Abstract][Full Text] [Related]
9. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment. Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689 [TBL] [Abstract][Full Text] [Related]
10. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma. Zou X; Mo Z Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261 [TBL] [Abstract][Full Text] [Related]
11. Rho GTPase-activating protein 4 is upregulated in Kidney Renal Clear Cell Carcinoma and associated with poor prognosis and immune infiltration. Xiao X; Lv X; Lin T; Li J; Wang R; Tian S; Liu X; Liu S; Jiang H; Yue D; Wang Y Cancer Biomark; 2024; 40(2):205-223. PubMed ID: 38905034 [TBL] [Abstract][Full Text] [Related]
12. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma. Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412 [No Abstract] [Full Text] [Related]
13. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma. Chang Y; Li N; Yuan W; Wang G; Wen J Int J Biochem Cell Biol; 2019 Nov; 116():105590. PubMed ID: 31442606 [TBL] [Abstract][Full Text] [Related]
14. Deciphering the Effects of the PYCR Family on Cell Function, Prognostic Value, Immune Infiltration in ccRCC and Pan-Cancer. Chen H; Chen Q; Chen J; Mao Y; Duan L; Ye D; Cheng W; Chen J; Gao X; Lin R; Lin W; Zhang M; Qi Y Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125668 [TBL] [Abstract][Full Text] [Related]
15. Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics. Wu H; Liu M; He Y; Meng G; Guo W; Guo Q BMC Cancer; 2021 Feb; 21(1):160. PubMed ID: 33581726 [TBL] [Abstract][Full Text] [Related]
16. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma. Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097 [TBL] [Abstract][Full Text] [Related]
17. ETV5-mediated upregulation of lncRNA CTBP1-DT as a ceRNA facilitates HGSOC progression by regulating miR-188-5p/MAP3K3 axis. Liu P; Fu R; Chen K; Zhang L; Wang S; Liang W; Zou H; Tao L; Jia W Cell Death Dis; 2021 Dec; 12(12):1146. PubMed ID: 34887384 [TBL] [Abstract][Full Text] [Related]
18. Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma. Xu K; Li D; Ji K; Zhang Y; Zhang M; Zhou H; Hou X; Jiang J; Zhang Z; Dai H; Sun H Biol Direct; 2024 Aug; 19(1):71. PubMed ID: 39175011 [TBL] [Abstract][Full Text] [Related]
19. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role. Zhong S; Chen S; Lin H; Luo Y; He J BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670 [TBL] [Abstract][Full Text] [Related]
20. Disulfidptosis-Related LncRNA Signatures for Prognostic Prediction in Kidney Renal Clear Cell Carcinoma. Feng K; Zhou S; Sheng Y; Lu K; Li C; Liu W; Kong H; Liu H; Mu Y; Zhang L; Zhang Q; Wang J Clin Genitourin Cancer; 2024 Aug; 22(4):102095. PubMed ID: 38833825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]